2005
DOI: 10.1111/j.1469-7580.2005.00492.x
|View full text |Cite
|
Sign up to set email alerts
|

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy

Abstract: In diabetic nephropathy, glomerular hypertrophy is evident early in response to hyperglycaemia. Alterations of capillary length and vascular remodelling that may contribute to glomerular hypertrophy and the subsequent development of glomerulosclerosis remain unclear. The present study used the db/db mouse model of Type 2 diabetes to examine the glomerular microvascular changes apparent with long-term diabetic complications. Unbiased stereological methods and high-resolution light microscopy were used to estima… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
74
2

Year Published

2009
2009
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 80 publications
(80 citation statements)
references
References 39 publications
4
74
2
Order By: Relevance
“…Increased glomerular capillary volume (one, but not the sole, cause of glomerular hypertrophy in diabetes) occurs as a consequence of an increase in the number, length, and surface area of glomerular capillaries and is mediated by an increase in both cell size and cell number. 5,36 The lack of effect of eNOS deficiency on this trophic response highlights that glomerular capillary growth in diabetes, although responsive to anti-VEGF therapy, is not strictly analogous to angiogenesis that occurs in other vascular beds, during development or in other disease states. That at least some VEGF-mediated processes may occur independently of downstream eNOS is readily illustrated by the observations that although eNOS 2/2 mice are viable and fertile, VEGF deletion results in embryonic lethality.…”
Section: Discussionmentioning
confidence: 99%
“…Increased glomerular capillary volume (one, but not the sole, cause of glomerular hypertrophy in diabetes) occurs as a consequence of an increase in the number, length, and surface area of glomerular capillaries and is mediated by an increase in both cell size and cell number. 5,36 The lack of effect of eNOS deficiency on this trophic response highlights that glomerular capillary growth in diabetes, although responsive to anti-VEGF therapy, is not strictly analogous to angiogenesis that occurs in other vascular beds, during development or in other disease states. That at least some VEGF-mediated processes may occur independently of downstream eNOS is readily illustrated by the observations that although eNOS 2/2 mice are viable and fertile, VEGF deletion results in embryonic lethality.…”
Section: Discussionmentioning
confidence: 99%
“…31,[47][48][49] In the renal circulation, there is increased renal angiogenesis in early stages of diabetes in both clinical and experimental studies. [50][51][52][53][54] These early vascular changes were attributed to increased VEGF expression and mild inflammation. 51,55 At later stages of diabetes, vascular regression occurs, where chronic inflammation leads to increases in vascular permeability, thickening of the glomerular basement membrane, endothelial cell apoptosis, and loss of peritubular capillaries.…”
Section: Diabetes and Neovascularizationmentioning
confidence: 99%
“…Glomerular size increases with normal body growth as well before and during multiple renal pathologies, including both diabetic nephropathy [13][14][15][16][17] and FSGS. [18][19][20][21][22][23][24] It has been suggested that an increase in glomerular size (also known as glomerular hypertrophy) is usually a compensatory mechanism that serves to match physiologic demands and sustain renal function.…”
mentioning
confidence: 99%